Differential effects of depot medroxyprogesterone acetate administration on vaginal microbiome in Hispanic White and Black women
ABSTRACTThe use of depot medroxyprogesterone acetate (DMPA), a 3-monthly injectable hormonal contraceptive, is associated with an increased risk of HIV acquisition possibly through alteration of the vaginal microbiome. In this longitudinal interventional study, we investigated the impact of DMPA adm...
Main Authors: | Liying Yang, Yuhan Hao, Jiyuan Hu, Dervla Kelly, Huilin Li, Stuart Brown, Carley Tasker, Natalie E. Roche, Theresa L. Chang, Zhiheng Pei |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-01-01
|
Series: | Emerging Microbes and Infections |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/22221751.2018.1563458 |
Similar Items
-
Sexual Dysfunction in Two Types of Hormonal Contraception: Combined Oral Contraceptives versus Depot Medroxyprogesterone Acetate
by: Nourossadat Kariman, et al.
Published: (2017-01-01) -
Dietary intake and eating behavior in depot medroxyprogesterone acetate users: a systematic review
by: P. Silva, et al.
Published: (2018-04-01) -
The effect of <i>Vigna unguiculata</i> on the estrogen receptor-α expression and the endometrial thickness in rats treated with depot medroxyprogesterone acetate (DMPA)
by: Rizki Fitrianingtyas, et al.
Published: (2023-12-01) -
A randomized crossover study to evaluate local tolerability following subcutaneous administration of a new depot medroxyprogesterone acetate contraceptive formulation
by: Vera Halpern, et al.
Published: (2023-01-01) -
Body composition, resting energy expenditure and inflammatory markers: impact in users of depot medroxyprogesterone acetate after 12 months follow-up
by: Gisele Almeida Batista, et al.
Published: (2016-09-01)